Instructions / Instruction for use: Oxyprogesterone capronate solution for injections in oleumI want this, give me price
Active substance Hydroxyprogesterone caproate
ATX code G03DA03 Hydroxyprogesterone
Estrogens, gestagens; Their homologues and antagonists
Antineoplastic hormonal agents and hormone antagonists
Nosological classification (ICD-10)
C50 Malignant neoplasm of breast
Cancer of the nipple and areola of the breast, Breast carcinoma, The hormone-dependent form of recurrent breast cancer in women in menopause, Hormone-dependent breast cancer, Disseminated breast carcinoma, Disseminated Breast Cancer, Malignant breast cancer, Malignant neoplasm of breast, Contralateral breast cancer, Locally advanced or metastatic breast cancer,Locally-distributed breast cancer, Locally-recurring breast cancer, Metastatic breast carcinoma, Metastasis of breast tumors, Metastatic breast carcinoma, Inoperable breast carcinoma, Incompatible breast cancer, Breast cancer in women with metastases, Breast cancer in men with metastases, Breast Cancer, Breast cancer in men, Mammary cancer, Breast cancer with distant metastases, Breast cancer in postmenopausal women, Breast cancer hormone-dependent, Breast cancer with local metastases, Breast cancer with metastases, Breast cancer with regional metastases,Breast cancer with metastases, Common hormone-dependent forms of breast cancer, Common Breast Cancer, Recurrent Breast Cancer, Recurrence of breast tumors, Breast cancer, Estrogen-dependent breast cancer, Estrogen-Dependent Breast Cancer, Disseminated breast cancer with overexpression of HER2, Tumors of the mammary glands
C53 Malignant neoplasm of cervix uteri
Intraepithelial neoplasm of cervix, Cervical carcinoma, Cervical cancer
C54 Malignant neoplasm of uterus
Uterine cancer, Cancer of the body of the uterus, Sarcoma of the uterus
N91 Lack of menstruation, meager and rare menstruation
Amenorrhea, Amenorrhea hypogonadotropic, Amenorrhea is prolactin-dependent, Oligomenorrhoea, Shortening of the secretory phase of the menstrual cycle, Menstrual disorders, Menstruation disorders, Prolactin-dependent amenorrhea without galactorrhea
N92 Abundant, frequent and irregular menstruation
Metromenorragii, Menorrhagia, Menorrhagia primary, Polymenorea, Idiopathic menorrhagia, Menorrhagia, Functional metronormorragia, Primary menorrhagia
N96 Habitual miscarriage
Miscarriage habitual, Habitual abortion, Habitual miscarriage
O20.0 Threatened abortion
Abortion threatening, threatening miscarriage, Spastic conditions with the risk of abortion, Threatened miscarriage in the first trimester of pregnancy, The threat of miscarriage, threatened abortion, The threat of miscarriage, Threatened spontaneous miscarriage
Composition and form of release
1 ampoule with 1 ml solution for injection in peach or olive oil contains 125 mg hydroxyprogesterone (12.5%) mg; In the box 10 pcs.
Pharmacological action - progestagenic.
Habitual and threatening miscarriage in the first half of pregnancy, amenorrhea and polymenorrhea, uterine cancer, breast cancer.
The second half of pregnancy.
Dosing and Administration
Intramuscularly (intramuscularly), 125-250 mg once a week during the first half of pregnancy. In amenorrhea primary or secondary - 250 mg once or in 2 divided doses. For polymenorrhea, 65-125 mg per 20-22 day of the cycle.
In the dark place.
Keep out of the reach of children.
Do not use after the expiry date printed on the package.